Physician profile
Kirby D Hitt
NPI 1083674642
$9,056,625.13
in general payments reported to CMS, 2019-2025
6 companies · $1.6M in 2025
The $1.6M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963K · 2020: $1.0M · 2021: $1.2M · 2022: $1.3M · 2023: $1.5M · 2024: $1.5M · 2025: $1.6M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.1M · Consulting Fee: $373K · Travel and Lodging: $136K · Food and Beverage: $9,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,123,308.66 |
| Consulting Fee | $373,000.00 |
| Travel and Lodging | $136,016.61 |
| Food and Beverage | $9,872.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $9,056,304.62 | 2019-2025 | Accolade, Triathlon, Mako |
| Next Science LLC | $130.36 | 2021 | |
| Orthosensor INC. | $82.03 | 2019 | |
| Abiomed | $51.21 | 2019 | |
| Onkos Surgical, INC. | $35.07 | 2024 | Eleos Limb Salvage System |
| Smith+Nephew, INC. | $21.84 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirby Hitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.